1. Home
  2. OPK vs NYAX Comparison

OPK vs NYAX Comparison

Compare OPK & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • NYAX
  • Stock Information
  • Founded
  • OPK 2007
  • NYAX 2005
  • Country
  • OPK United States
  • NYAX Israel
  • Employees
  • OPK N/A
  • NYAX N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • NYAX
  • Sector
  • OPK Health Care
  • NYAX
  • Exchange
  • OPK Nasdaq
  • NYAX Nasdaq
  • Market Cap
  • OPK 1.0B
  • NYAX 1.7B
  • IPO Year
  • OPK 1995
  • NYAX N/A
  • Fundamental
  • Price
  • OPK $1.39
  • NYAX $46.16
  • Analyst Decision
  • OPK Buy
  • NYAX Buy
  • Analyst Count
  • OPK 4
  • NYAX 7
  • Target Price
  • OPK $2.75
  • NYAX $42.00
  • AVG Volume (30 Days)
  • OPK 2.0M
  • NYAX 11.4K
  • Earning Date
  • OPK 11-06-2025
  • NYAX 11-11-2025
  • Dividend Yield
  • OPK N/A
  • NYAX N/A
  • EPS Growth
  • OPK N/A
  • NYAX N/A
  • EPS
  • OPK N/A
  • NYAX 0.57
  • Revenue
  • OPK $664,029,000.00
  • NYAX $348,663,000.00
  • Revenue This Year
  • OPK N/A
  • NYAX $31.84
  • Revenue Next Year
  • OPK $0.84
  • NYAX $22.85
  • P/E Ratio
  • OPK N/A
  • NYAX $81.56
  • Revenue Growth
  • OPK N/A
  • NYAX 29.63
  • 52 Week Low
  • OPK $1.11
  • NYAX $23.52
  • 52 Week High
  • OPK $2.04
  • NYAX $52.46
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • NYAX 42.14
  • Support Level
  • OPK $1.34
  • NYAX $46.33
  • Resistance Level
  • OPK $1.44
  • NYAX $51.03
  • Average True Range (ATR)
  • OPK 0.04
  • NYAX 1.05
  • MACD
  • OPK -0.00
  • NYAX -0.38
  • Stochastic Oscillator
  • OPK 50.00
  • NYAX 3.18

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: